Critical appraisal:Altamura D, Avramidis M, Menzies SW 2008 2

From Cancer Guidelines Wiki

Risk of bias assessment: cohort study

Subject selection
"New technology" group
Representative of eligible patients.
Comparison group
Representative of eligible patients
Comparability of groups on demographic characteristics and clinical features
Comparable
Measurement of outcomes
Outcome measures blind to technology used
No or not described
Same method of measurement used across comparison groups
No or not described
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
No or not described
Overall risk of bias
Moderate risk of bias Additional comments: Please replace this text and include any additional comments in regards to your risk of bias rating


Jutta's tick icon.png This appraisal has been completed.


Article
Altamura D, Avramidis M, Menzies SW. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol 2008 Apr;144(4):502-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18427044.
Assigned to
User:Tamsin.parrish
Topic area
Guidelines:Melanoma
Clinical question
Form
Form:Quality appraisal cohort


Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment